$47.38
00.00%
Last update: 4:00 PM
15 minutes delayed
Agios Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Agios Pharmaceuticals using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-01 | $-1.69 | $-1.59 | -6.29 % |
Mar 2024 | 2024-05-02 | $-1.45 | $-1.65 | 12.1 % |
Dec 2023 | 2024-02-15 | $-1.72 | $-1.65 | -4.24 % |
Sep 2023 | 2023-11-02 | $-1.64 | $-1.70 | 3.53 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-01 | $8.62M | $9.75M | -11.6 % |
Mar 2024 | 2024-05-02 | $8.19M | $8.37M | -2.16 % |
Dec 2023 | 2024-02-15 | $7.10M | $7.94M | -10.5 % |
Sep 2023 | 2023-11-02 | $7.40M | $7.52M | -1.61 % |
Agios Pharmaceuticals (AGIO) is scheduled to report earnings on October 31, 2024. The last reported earnings were for reported on August 1, 2024 for Q2.
The Actual EPS was $-1.69, which missed the estimate of $-1.59.
The Actual Revenue was $8.6M, which missed the estimate of $9.8M.
Browse earnings estimates, EPS, and revenue on all stocks.